Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: A systematic review

Pediatric Blood and Cancer

Volumn 58, Issue 5, 2012, Pages 665-674

  Braam, Katja I ^a   Overbeek, Annelies ^a   Kaspers, Gertjan J L ^a   Ronckers, Cecile M ^b,c   Schouten van Meeteren, Annette Y N ^b   Van Dulmen Den Broeder, Eline ^a   Veening, Margreet A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

Author keywords

Childhood cancer; Childhood cancer survivor; Melanoma; Second malignant neoplasm

Indexed keywords

ALKYLATING AGENT; CHLORMETHINE; CYTOSTATIC AGENT;

CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CHEMORADIOTHERAPY; CHILDHOOD CANCER; ENUCLEATION; FAMILY HISTORY; FOLLOW UP; HODGKIN DISEASE; HUMAN; LEUKEMIA; MELANOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; SECOND CANCER; SEX DIFFERENCE; SOFT TISSUE SARCOMA; SYSTEMATIC REVIEW;

FEMALE; HUMANS; MALE; MELANOMA; NEOPLASMS, SECOND PRIMARY; RETINAL NEOPLASMS; RETINOBLASTOMA; RISK FACTORS; SEX FACTORS; SURVIVORS; TIME FACTORS;

EID: 84857821986     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24023     Document Type: Review

References (44)

1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008., based on November 2010 SEER data submission, posted to the SEER web site, 2011 April 15 Available from: URL:
2. Cardous-Ubbink MC, Heinen RC, Bakker PJ, et al. Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer 2007; 43: 351-362.
3. Davies SM. Subsequent malignant neoplasms in survivors of childhood cancer: Childhood Cancer Survivor Study (CCSS) studies. Pediatr Blood Cancer 2007; 48: 727-730.
4. Reulen RC, Winter DL, Frobisher C, et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA 2010; 304: 172-179.
5. Jen M, Murphy M, Grant-Kels JM. Childhood melanoma. Clin Dermatol 2009; 27: 529-536.
6. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85: 1121-1128.
7. Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004; 96: 357-363.
8. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ 2001; 323: 224-228.
9. Opocher E, Kremer LC, Da Dallt L, et al. Prognostic factors for progression of childhood optic pathway glioma: A systematic review. Eur J Cancer 2006; 42: 1807-1816.
10. Van der Pal HJ, Van Dalen EC, Kremer LC, et al. Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: A systematic review. Cancer Treat Rev 2005; 31: 173-185.
11. Beaty O, Hudson MM, Greenwald C, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995; 13: 603-609.
12. Bluhm EC, Ronckers C, Hayashi RJ, et al. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study. Blood 2008; 111: 4014-4021.
13. Borgmann A, Zinn C, Hartmann R, et al. Secondary malignant neoplasms after intensive treatment of relapse acute lymphoblastic leukaemia in childhood. Eur J Cancer 2008; 44: 257-268.
14. Brunetti D, Tamaro P, Fanin R, et al. Family history of cancer and risk of second malignancies in young cancer patients in Trieste, Italy. Int J Cancer 2005; 115: 814-821.
15. Cohen RJ, Curtis RE, Inskip PD, et al. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 2005; 103: 2391-2396.
16. Constine LS, Tarbell N, Hudson MM, et al. Subsequent malignancies in children treated for Hodgkin's disease: Associations with gender and radiation dose. Int J Radiat Oncol Biol Phys 2008; 72: 24-33.
17. Corpron CA, Black CT, Ross MI, et al. Melanoma as a second malignant neoplasm after childhood cancer. Am J Surg 1996; 172: 459-461.
18. Gold DG, Neglia JP, Dusenbery KE. Second neoplasms after megavoltage radiation for pediatric tumors. Cancer 2003; 97: 2588-2596.
19. Green DM, Hyland A, Barcos MP, et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 2000; 18: 1492-1499.
20. Guérin S, Dupuy A, Anderson H, et al. Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer 2003; 39: 2379-2386.
21. Hijiya N, Hudson MM, Lensing S, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 2007; 297: 1207-1215.
22. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 2007; 121: 2233-2240.
23. Li FP, Cassady JR, Jaffe N. Risk of second tumors in survivors of childhood cancer. Cancer 1975; 35: 1230-1235.
24. MacCarthy A, Bayne AM, Draper GJ, et al. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol 2009; 93: 1159-1162.
25. Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst 2008; 100: 1771-1779.
26. Maule M, Scelo G, Pastore G, et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: An international study. J Natl Cancer Ins 2007; 99: 790-800.
27. Paulino AC, Fowler BZ. Secondary neoplasms after radiotherapy for a childhood solid tumor. Pediatr Hematol Oncol 2005; 22: 89-101.
28. Pratt CB, Meyer WH, Luo X, et al. Second malignant neoplasms occuring in survivors of osteosarcoma. Cancer 1997; 80: 960-965.
29. Smith MB, Xue H, Strong L, et al. Forty-year experience with second malignancies after treatment of childhood cancer: Analysis of outcome following the development of the second malignancy. J Pediatr Surg 1993; 28: 1342-1348.
30. Caglar K, Varan A, Akyüz C, et al. Second neoplasms in pediatric patients treated for cancer: A center's 30-year experience. J Pediatr Hematol Oncol 2006; 28: 374-378.
31. Kaatsch P, Debling D, Blettner M, et al. Second malignant neoplasms after childhood cancer in Germany. Results from the long-term follow-up of the German Childhood Cancer Registry. Strahlenther Onkol 2009; 185: 8-10.
32. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. J Clin Oncol 2005; 23: 2272-2279.
33. Metayer C, Lynch CF, Clarke EA, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000; 18: 2435-2443.
34. Socié G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348-357.
35. Stavrou T, Bromley CM, Nicholson HS, et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 2001; 23: 431-436.
36. Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 2010; 102: 1083-1095.
37. Nelson A, Tsao H. Melanoma and genetics. Clin Dermatol 2009; 27: 46-52.
38. Kony SJ, De Vathaire F, Chompret A, et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997; 350: 91-95.
39. Leone G, Fianchi L, Voso MT. Therapy-related myeloid neoplasms. Curr Opin Oncol 2011; DOI: 10.1097/CCO.0b013e32834bcc2a.
40. Baird EA, McHenry PM, MacKie RM. Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi. BMJ 1992; 305: 799-801.
41. De Wit PEJ, De Vaan GAM, De Boo TM, et al. Prevalence of naevocytic naevi after chemotherapy for childhood cancer. Med Pediatr Oncol 1990; 18: 336-338.
42. Hughes BR, Cunliffe WJ, Bailey CC. Excess benign melanocytic naeviafter chemotherapy for malignancy in childhood. BMJ 1989; 299: 88-91.
43. Naldi L, Adamoli L, Fraschini D, et al. Number and distribution of melanocytic nevi in individuals with a history of childhood leukaemia. Cancer 1996; 77: 1402-1408.
44. Garbe C, Buttner P, Weiss J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: Multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102: 695-699.